Surgery gets its test harness 🤖, Candid's $120M billing bet 🧾, A pastor sues ChatGPT 🙏
⚡ Around the Wards
Surgery gets its test harness — Inner Logic raised $11.5M (General Catalyst + Bison Ventures) to simulate thousands of virtual patients so procedural devices get validated before they touch anyone. The autonomy is downstream; the test harness is the product. (Full below.)
Candid Health grabbed $120M (Series D, Sixth Street Growth) to go after the ~$280B US billing mess with autonomous RCM — 3x its Feb-2025 valuation.
A Florida pastor is suing OpenAI — he says spiritually-framed ChatGPT advice delayed his care until a near-fatal pulmonary embolism. He’s asking a court to halt ChatGPT Health until independent evaluators clear it.
PointClickCare set an August 7 kill-date for browser extensions — the biggest SNF EHR is evicting the integration pattern a lot of startups quietly run on. Bots get their own deadline soon.
🎧 Podcast: Relentless Health Value — “How RCM Became a $200 Billion Hot Potato” — the analyst’s line for builders: whoever has the least scale “gets outstaffed on paperwork.” Every dollar spent fighting over who pays is a dollar you can attack.
🧭 The Curbside
“Anthropic shipped ‘Record a Skill’ — does that change what a clinician can actually build?”
Short answer: Yes, at the margin — it collapses the hardest part of building an agent (describing your own tacit workflow) into just doing it once on camera.
What changed: Claude Cowork now lets you screen-record a task, narrate as you go, and have it turned into a reusable skill — generally available now for Pro/Max/Team, not a preview.
Builder read / Watchout: The whole value is capturing an expert’s exceptions and reasoning without writing docs. But it records your screen, clicks, and keystrokes — so you record it on synthetic data, never over a live chart. The demo becomes the spec; the governance is still yours to add.
🔮 My bet: “show it once” becomes the default way clinicians hand a workflow to an agent, and prompt-writing starts to feel like assembly language.
“Everyone keeps calling real-time claims adjudication ‘technically ready.’ Is it?”
Short answer: The tech is ready. The incentive isn’t.
What changed / Evidence: A fresh look at why we still don’t have it lands on the same wall — payers earn float by holding the money, so nothing adjudicates in real time until CMS mandates it (CMS-0057’s FHIR APIs are the closest template).
😤 Haters: “So there’s no product here.” There’s a huge one — a pre-submission scrubber that tells a clinician before they file whether this claim clears the payer’s own rules. You don’t need real-time adjudication from the payer if you can simulate their answer first.
🔬 The Big Thing
Is the story “robot surgeons are coming” — or “someone finally figured out what the hard part actually is”?
Inner Logic just raised an $11.5M seed, co-led by General Catalyst and Bison Ventures.
Everyone will read the headline as “autonomous surgery.” That’s not what they’re building.
They’re building the layer underneath autonomy: simulation infrastructure that runs a procedural device through thousands of virtual patients — different anatomies, different failure modes — before it ever touches a real gallbladder.
The robot that can operate isn’t the bottleneck anymore. The thing that decides when it’s allowed to is. And that thing is a validation problem, not a robotics problem.
Here’s why that’s the whole thesis of this newsletter in one company. Validation is a domain-expertise problem. Who knows the anatomy that isn’t in the textbook, the bleed that changes what the tissue looks like, the detour a procedure takes when the patient isn’t the average? The surgeon does.
You can vibe-code a robot arm. You cannot vibe-code the knowledge of how a cholecystectomy goes wrong.
There’s also a quieter, deeper point hiding in here. A simulation is a map. The patient on the table is the territory. No test harness can fully contain the thing it’s testing — you validate against the failure modes you thought to model, and the OR specializes in the ones you didn’t. Simulation buys you enormous confidence and never certainty, and the gap between the two is exactly where clinical judgment still lives.
😤 “This is just a fancy CRO for device companies.” Maybe. But “fancy CRO” undersells where the value moves. When the bottleneck to shipping a procedural device is validation, the company that owns the validation harness owns the chokepoint every device maker has to pass through. That’s not a services business, that’s a toll road.
😤 “Simulated patients will never capture real ones.” Correct, and that’s the point, not the objection. You’re not trying to replace the real trial — you’re trying to fail cheaply, thousands of times, before you fail expensively once. The map isn’t the territory. It’s still the best thing you have before you’re standing in the territory.
😤 “Autonomy in soft tissue is a decade out.” Go tell that to the pig. (See today’s BTW.)
❓ What’s the clinician-built product that sits between “the device is validated in sim” and “I trust it on my patient”? A personal torture-test suite a surgeon brings to every vendor — their own hardest 20 cases, run against the vendor’s model, live? I think there’s a real product in owning the acceptance test rather than reading the vendor’s. Can’t quite name it yet.
📡 Builder’s Radar
Candid Health raised $120M to make billing autonomous — and tripled its valuation doing it
Candid Health closed a $120M Series D led by Sixth Street Growth (Oak HC/FT, 8VC, Y Combinator in), pointing autonomous agents at the ~$280B Americans spend every year adjudicating who pays. 190% YoY contracted revenue, 200+ orgs.
The tell isn’t the raise — it’s that RCM is now the second nine-figure AI-billing round in a week. The money has decided the paperwork is the product.
If a startup can autonomously code and submit claims, the moat is the denial data, not the model — whoever’s seen the most rejections knows the most rules.
😤 “RCM is a race to the bottom.” It’s a race to whoever has the cleanest feedback loop. Every denied claim is a labeled training example the incumbents already own and startups have to earn. That’s a data moat, not a pricing war.
A pastor collapsed mid-sermon. Now he’s suing to shut ChatGPT Health down.
Scott Winters, a former Florida evangelical pastor, sued OpenAI and Sam Altman alleging ChatGPT gave him dangerous, spiritually-couched medical advice that led him to delay care until a massive pulmonary embolism.
Eight causes of action, including negligence and the unauthorized practice of medicine. He isn’t just seeking damages — he wants the court to freeze ChatGPT Health until independent evaluators say it’s safe.
Whatever the merits, this is the case every builder shipping an LLM near patients should read twice — it’s the first serious attempt to make “practice of medicine” attach to a chatbot.
😤 “He typed the questions himself — that’s on him.” That defense works right up until a court decides the product was designed to maximize engagement over safety. Then “the user chose to trust it” becomes “you built it to be trusted.” That’s the whole fight.
😤 “This will get dismissed.” Probably parts of it. But the injunctive ask — independent safety evals before a health chatbot can operate — is exactly the governance a lot of us have been saying should exist anyway. The lawsuit might build it faster than the regulators do.
HCA’s AI story is boring, at scale — which is exactly why it’s worth reading
HCA detailed its enterprise AI approach: its Timpani scheduling platform is live at 130+ hospitals and 1,200+ nursing departments, cutting a scheduling cycle to 2–3 hours, with a reported 6% drop in turnover and less contract labor. A separate gen-AI nurse-handoff tool runs on Google Cloud.
No moonshot. Just the unglamorous single-owner workflow (staffing) shipped to a whole system.
🔮 Where this lands: the enterprise AI that actually scales in 2026 keeps being scheduling, handoffs, and staffing — not diagnosis. My bet: the next two years of real health-system AI budget goes to the back office, and the clinical-decision tools ride in behind them once the plumbing is trusted.
Quick hits
Assured raised $19M (Insight Partners) for AI agents that execute credentialing, licensing, and payer enrollment — provider-operations as the next agent beachhead. Houston Methodist among 100+ orgs.
MaineHealth nurses are rallying today against its Palantir analytics tool while leadership defends it — another data point that the fight over operational AI is now happening on the sidewalk, not just the governance committee.
🎙️ From the Pods
🎙️ Relentless Health Value — “How Revenue Cycle Management Became a $200 Billion Healthcare Hot Potato” (Stacey Richter with analyst Andrew Tsang)
Roughly a third of every healthcare dollar goes to the fight over who pays, not to care — and the cost always rolls downhill to whoever has the least leverage: the patient, the solo practice, the small self-funded employer.
🔇 Speaker Blindspot: False dichotomy. He offers a clean binary — play the potato game or opt out via direct contracting — minutes after explaining the system breaks on rare $4M gene-therapy cases that no up-front handshake can pre-price. The escape hatch he’s selling doesn’t cover the very failure mode he identified.
🎙️ Podnosis — “A More Connected Approach to Prenatal Care” (Anastassia Gliadkovskaya; guest Dr. Elizabeth Cherot, Chief Medical Officer, Unified Women’s Healthcare)
Their engine risk-stratifies pregnant patients daily off payer + EMR data and flags pregnancies ~4x faster than payers can. The kicker: the identical outreach converts when it comes from the care team and gets ignored when it comes from the insurer.
💡 Builder take: The moat is distribution and trust, not the model. “When my phone rings and it’s my insurance, I don’t want to answer that.” Same algorithm, different sender, opposite result — build for the channel patients actually pick up.
🔇 Speaker Blindspot: Appeal to authority / anchoring. Asked directly about racial bias in a population where Black women die at 3–4x the rate, she vouches for the model because it’s “really well proven” on 600,000 moms. A large, coding-based, laggy payer dataset can scale a disparity as easily as surface it — sample size isn’t fairness.
💡 BTW
💡 BTW: Inner Logic’s Chief Robotics Officer, Dr. Axel Krieger, is the Johns Hopkins engineer whose STAR robot performed the first autonomous robotic soft-tissue surgery on a live pig back in 2022 — reconnecting intestine, on its own, and by some measures better than a human surgeon. When he tells you validation infrastructure is the missing piece for surgical autonomy, he’s talking from the far side of it.
What are you building this week? Email and tell me (kevin@clinicians.build) — I read every one.
— Kevin & AI